6e CH 07 Transcriptional Control of Gene Expression
6e CH 07 Transcriptional Control of Gene Expression
Nombre _____________________________________________________________________________
2. Which of the following statements regarding the E. coli two-component PhoR/PhoB regulatory system
is (are) true?
a. PhoB has kinase activity.
b. PhoB is a cytosolic protein.
c. Phosphorylated PhoB is an inactive transcriptional activator.
d. none of the above
3. How does binding of the lac repressor to the lac operator block transcription initiation?
a. lac repressor binding blocks RNA polymerase from interacting with DNA at the start site
b. lac repressor binding induces a DNase that cleaves the DNA at the transcription start site
c. lac repressor binding causes a conformational change in RNA polymerase
d. lac repressor binding induces a protease that degrades the sigma subunit of RNA polymerase
6. All of the following statements about the essential carboxy terminal domain (CTD) of RNA polymerase
are true except
a. The CTD is present in RNA polymerase I, II, and III.
b. The CTD can become phosphorylated.
c. The CTD is critical for viability.
d. The CTD of mammals contains more than 50 repeats of a heptapeptide.
7. An enhancer
a. is a DNA element that stimulates transcription of eukaryotic promoters.
b. binds to RNA polymerase and stimulates transcription.
c. acts as a binding site for RNA polymerase.
d. interacts with repressor proteins to enhance transcriptional repression.
10. Which of the following is not used in the electrophoretic mobility shift assay (EMSA)?
a. a radiolabeled DNA fragment
b. a polyacrylamide gel
c. a DNA binding protein
d. DNase I
11. Which of the following proteins does not “footprint” the lac operon control region?
a. lac repressor
b. b-galactosidase
c. RNA polymerase
d. cAMP-CAP
12. All the following statements about the Wilms’s tumor (WT1) gene or WT1 protein are true except
a. Loss-of-function WT1 protein leads to the development of kidney tumors.
b. The WT1 protein has a zinc finger binding domain.
c. WT1 protein is a transcription activator.
d. WT1 binds to the control region of the EGR1 gene.
14. Which of the following is not a structural motif found in a DNA-binding domain?
a. homeodomain
b. zinc-finger
c. helix-loop-helix
d. random-coil acidic domain
15. Which of the following is the correct order of binding of general transcription factors to initiate
transcription at RNA polymerase II promoters?
a. TFIID, TFIIB, Pol II, TFIIH
b. PolII, TFIID, TFIIB, TFIIH
c. TFIIB, PolII, TFIIH, TFIID
d. TFIID, TFIIH, TFIIB, PolII
17. All the following statements about heterochromatin are true except
Transcriptional Control of Gene Expression
a. Heterochromatin stains more darkly with DNA dyes than does euchromatin.
b. Heterochromatin contains more highly condensed DNA than does euchromatin.
c. Heterochromatin is associated with inactive genes.
d. Heterochromatin is more susceptible to DNaseI than is euchromatin.
18. All of the following events play a role in yeast mating type switching except
a. methylation of the silent-mating-type locus.
b. transcription of the gene at the MAT locus.
c. chromatin condensation at the silent mating type locus.
d. a recombination event known as gene conversion.
24. Which of the following statement(s) regarding the transcription initiation and RNA Pol III is (are)
true?
a. ATP hydrolysis is not required for initiation.
b. Pol III is responsible for synthesizing tRNAs and 5S-rRNA.
c. The promoter elements of tRNA genes lie entirely within the transcribed sequence.
d. all of the above
Transcriptional Control of Gene Expression
Nombre _____________________________________________________________________________
1. Describe the similarities and differences between prokaryotic and eukaryotic RNA polymerases.
2. Describe the structure and function of the carboxy terminal domain (CTD) of RNA polymerase II.
3. What is the functional difference between enhancers and promoter proximal elements?
4. Describe how the electrophoretic mobility shift assay (EMSA) and the DNase I footprinting
techniques are used to identify DNA-protein interactions.
5. What is an enhancesome?
10. Describe the role of histone deacetylation and hyperacetylation in yeast transcriptional control.
11. Describe how lipid soluble hormones, glucocorticoid for example, regulate gene transcription acting
through nuclear hormone receptors.
12. Describe the mechanism of transcriptional control for the heat shock genes. What advantage does this
type of control impart to the cell?